[Sexual health after radiotherapy]

Area of Science:

• Oncology
• Radiotherapy
• Sexual Health

Background:

• Locoregional toxicity from radiotherapy can significantly impair patient quality of life.
• Sexual function is a crucial aspect of well-being, often overlooked in cancer survivorship.
• Several cancer sites, including breast, prostate, pelvic, and ENT regions, directly impact intimate health.

Purpose of the Study:

• To review the impact of locoregional radiotherapy toxicity on sexual function.
• To identify specific cancer sites where sexual health is commonly affected.
• To highlight the potential for psychological and somatic changes impacting sexuality in all cancer patients.

Main Methods:

• Literature review of studies on radiotherapy and sexual function.
• Analysis of data concerning specific cancer types (breast, prostate, pelvic, ENT).
• Consideration of broader psychological and somatic effects on sexuality.

Main Results:

• Radiotherapy-induced locoregional toxicity is a significant factor affecting sexual function.
• Cancers of the breast, prostate, pelvic, and ENT regions frequently involve organs critical to sexual health.
• A comprehensive range of psychological and somatic changes can lead to sexual dysfunction in cancer survivors.

Conclusions:

• Understanding and addressing radiotherapy's impact on sexual function is essential for comprehensive cancer care.
• Interventions should consider both physical and psychological aspects of sexual health post-treatment.
• Further research is needed to develop effective strategies for preserving sexual well-being in cancer patients.